Zydus Lifesciences Dissolves French Subsidiary Ampliman 2
Written By : Susmita Roy
Published On 2026-01-11 05:26 GMT | Update On 2026-01-11 05:26 GMT
Advertisement
New Delhi: Zydus Lifesciences Ltd has informed that Ampliman 2, France, a step-down wholly owned subsidiary of the company, has been dissolved without liquidation, effective January 9, 2026, according to a regulatory filing.
Ampliman 2 was a wholly owned subsidiary of Zydus MedTech (France) S.A.S., which in turn is a step-down wholly owned subsidiary of Zydus Lifesciences. Following the dissolution, all assets and liabilities of Ampliman 2 have been transferred to Zydus MedTech (France) S.A.S., the company said in its disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.